Related Experiment Video
Updated: Aug 19, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2
1Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, La Jolla 92093, USA.
Abstract:
IL-1 inhibits chondrocyte proliferation induced by TGF beta or serum. This study analyzed the role of nitric oxide (NO), which is induced at high levels by IL-1 in chondrocytes. NO, when administered through sodium nitroprusside (SNP), inhibited TGF beta or serum-induced chondrocyte proliferation. To determine whether IL-1-induced NO is responsible for growth inhibition by IL-1, chondrocytes were cultured in the presence of the nitric oxide synthase inhibitor N-monomethyl-L-arginine (NMA), which dose-dependently reduced the antiproliferative effects of IL-1. Analysis of interactions between PGE2, a known chondrocyte growth inhibitor, and NO showed that PGE2 does not induce NO and is not required for NO induction by IL-1. However, SNP induced high levels of PGE2, and NMA reduced IL-1-induced PGE2. This raised the possibility that PGE2 is a downstream mediator of the antiproliferative effects of NO. This was confirmed in experiments where the growth inhibitory effects of SNP were reduced by indomethacin. These results suggest that the chondrocyte growth inhibition by IL-1 in chondrocytes is due to the induction of NO, which stimulates the production of PGE2 as a mediator of its antiproliferative effects.
Insights
Interleukin-1 (IL-1) inhibits chondrocyte proliferation by inducing nitric oxide (NO). This NO then stimulates prostaglandin E2 (PGE2) production, mediating the antiproliferative effect and inhibiting chondrocyte growth.
Area of Science:
- Cell Biology
- Biochemistry
- Immunology
Background:
- Interleukin-1 (IL-1) is known to inhibit chondrocyte proliferation.
- Nitric oxide (NO) is significantly induced by IL-1 in chondrocytes.
- Prostaglandin E2 (PGE2) is a known inhibitor of chondrocyte growth.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) in IL-1-induced chondrocyte growth inhibition.
- To elucidate the relationship between NO, PGE2, and chondrocyte proliferation.
- To determine if NO mediates the antiproliferative effects of IL-1.
Main Methods:
- Chondrocytes were treated with IL-1, TGF-beta, or serum.
- Nitric oxide synthase inhibitor N-monomethyl-L-arginine (NMA) was used to block NO production.
- Sodium nitroprusside (SNP) was used to administer NO.
- Indomethacin was used to inhibit prostaglandin synthesis.
Main Results:
- Nitric oxide (NO), administered via SNP, inhibited TGF-beta or serum-induced chondrocyte proliferation.
- NMA dose-dependently reduced the antiproliferative effects of IL-1, indicating NO's role.
- SNP induced high levels of PGE2, and NMA reduced IL-1-induced PGE2.
- Indomethacin reduced the growth inhibitory effects of SNP, confirming PGE2 as a mediator.
Conclusions:
- IL-1-induced chondrocyte growth inhibition is mediated by the induction of nitric oxide (NO).
- NO stimulates the production of PGE2, which acts as a downstream mediator of NO's antiproliferative effects.
- This pathway highlights a novel mechanism for regulating chondrocyte proliferation in response to IL-1.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Gastritis II: Pathophysiology